1/ #EHRA_ESC tweetorial on anticoagulation & stroke prevention.
#EPeeps, after having done an overview #tweetorial on the new @escardio#AFib guidelines 2020 👉bit.ly/2ITAbCq, I will go more in depth into several topics of these guidelines in the next weeks
3/ I think that this figure which summarizes OAC in #AFib is very didactic and practical. Please note that NOACS are generally recommended as first line therapy for OAC.
4/ Very important:
even if the risk of ischaemic stroke is higher with persistent #AFib compared to paroxysmal, the temporal pattern should not affect the decision regarding long-term OAC.
5/ Patients with prosthetic mechanical heart valve or moderate to severe mitral stenosis are indicated for VKA, not NOACs. Be careful!
6/ Calculate the CHA2DS2-VASc score. This is critical and is often not well performed. For example, the C letter not only stands for #HeartFailure but also asymptomatic LV dysfunction or hypertrophic cardiomyopathy.
7/ Identify patients at low stroke risk i.e. patients with CHA2DS2-VASc score 0 for men and 1 for women.
🚫These patients do not require OAC.
But a periodic revaluation is recommended.
8/ Calculate the HAS-BLED score to identify patients with a high bleeding risk.
High bleeding risk is determined when HAS-BLED ≥3.
All modifiable risk factors of bleeding should be addressed.
First, let’s take a look at the "what’s new" part.
3/24
ECG documentation is required to establish the diagnosis of #AFib (either standard 12-lead ECG recording or single-lead ECG tracing of at least 30 s).
I think that this is important because now we can explicitly diagnose AF with single-lead ECGs. #wEHRAbles